Ludwig Patzer

St. Elisabeth And St
Halle, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Markers and regulators of osteoblast and osteoclast activity in children with X-linked hypophosphatemia treated with burosumab.

Markers and regulators of osteoblast and osteoclast activity in children with X-linked hypophosphatemia treated with burosumab.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: October 30, 2025

Anthropometric characteristics at birth and growth outcome in patients with X-linked hypophosphatemia treated with oral phosphate and active vitamin D.

Anthropometric characteristics at birth and growth outcome in patients with X-linked hypophosphatemia treated with oral phosphate and active vitamin D.

Journal: Pediatric nephrology (Berlin, Germany)

Published: September 09, 2025

Growth dynamics of transversal body dimensions and proportions, with related clinical determinants in children with X-linked hypophosphatemia treated with phosphate supplements and active vitamin D.

Growth dynamics of transversal body dimensions and proportions, with related clinical determinants in children with X-linked hypophosphatemia treated with phosphate supplements and active vitamin D.

Journal: Pediatric nephrology (Berlin, Germany)

Published: February 08, 2025

Office Blood Pressure and Obesity in Children with X-Linked Hypophosphatemia.

Office Blood Pressure and Obesity in Children with X-Linked Hypophosphatemia.

Journal: Calcified tissue international

Published: December 11, 2024

Health-related quality of life of children with X-linked hypophosphatemia in Germany.

Health-related quality of life of children with X-linked hypophosphatemia in Germany.

Journal: Pediatric nephrology (Berlin, Germany)

Published: March 08, 2024

Renal and Extrarenal Phenotypes in Patients With HNF1B Variants and Chromosome 17q12 Microdeletions.

Renal and Extrarenal Phenotypes in Patients With HNF1B Variants and Chromosome 17q12 Microdeletions.

Journal: Kidney international reports

Published: February 13, 2024

Is there a dominant-negative effect in individuals with heterozygous disease-causing variants in COL4A3/COL4A4?

Is there a dominant-negative effect in individuals with heterozygous disease-causing variants in COL4A3/COL4A4?

Journal: Clinical genetics

Published: October 29, 2023

Correction: Potential Benefit of Probiotic E. Coli Nissle in Term Neonates.

Correction: Potential Benefit of Probiotic E. Coli Nissle in Term Neonates.

Journal: Klinische Padiatrie

Published: December 13, 2022

Potential Benefit of Probiotic E. Coli Nissle in Term Neonates.

Potential Benefit of Probiotic E. Coli Nissle in Term Neonates.

Journal: Klinische Padiatrie

Published: November 29, 2022

Effects of Burosumab Treatment on Mineral Metabolism in Children and Adolescents With X-linked Hypophosphatemia.

Effects of Burosumab Treatment on Mineral Metabolism in Children and Adolescents With X-linked Hypophosphatemia.

Journal: The Journal of clinical endocrinology and metabolism

Published: November 25, 2022

Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.

Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.

Journal: Molecular genetics and metabolism

Published: June 26, 2022

Renal X-inactivation in female individuals with X-linked Alport syndrome primarily determined by age.

Renal X-inactivation in female individuals with X-linked Alport syndrome primarily determined by age.

Journal: Frontiers in medicine

Published: May 26, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026